{
  "ptid_time": "041_S_4143_2012-02-23",
  "img_path": "/data/qiuhui/data/adni/images/041_S_4143/2012-02-23/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 49,903 mm³, 123.4% above the reference mean. With a Z-score of 3.09 (99.9th percentile), this represents profound enlargement; hippocampal volume measures 5,257 mm³, 31.6% below the reference mean. With a Z-score of -3.55 (0.0th percentile), this represents profound atrophy; whole brain volume measures 903,386 mm³, 12.2% below the reference mean. With a Z-score of -1.52 (6.4th percentile), this represents moderate atrophy; entorhinal cortex volume measures 1,954 mm³, 49.8% below the reference mean. With a Z-score of -3.86 (0.0th percentile), this represents profound atrophy; fusiform gyrus volume measures 14,750 mm³, 19.0% below the reference mean. With a Z-score of -2.14 (1.6th percentile), this represents significant atrophy; middle temporal gyrus volume measures 17,986 mm³, 12.3% below the reference mean. With a Z-score of -1.10 (13.6th percentile), this represents mild atrophy. ",
  "text_data": "Age is 64.1 years. Gender is Female. Education: 19 years. MMSE: 30.0. MoCA: 24.0. APOEε4 alleles: 0.0. ",
  "true_diagnosis": "Diagnosis: MCI.",
  "gpt_diagnosis": "**Reasoning:** The imaging data show profound atrophy in key Alzheimer's-related regions (hippocampus, entorhinal cortex) and significant ventricular enlargement, strongly suggestive of neurodegeneration. However, the MMSE is normal (30/30), while the MoCA (24/30) indicates mild cognitive impairment, creating a discrepancy between structural and cognitive findings.  \n\n**Diagnosis:** **Mild Cognitive Impairment (MCI)**  \n**Confidence:** **Medium** (High confidence in structural neurodegeneration, but cognitive scores are borderline, and APOE4-negative status slightly reduces Alzheimer's likelihood.)  \n\n*Note:* The profound atrophy in Alzheimer’s-vulnerable regions suggests high risk for progression to dementia, but the current cognitive profile aligns more closely with MCI. Clinical correlation (longitudinal follow-up, CSF/biomarkers) would strengthen diagnostic certainty.",
  "timestamp": "2025-07-26T07:13:37.771515"
}